Wells Fargo’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,464
Closed -$3.14K 7840
2023
Q3
$3.14K Sell
2,464
-73,443
-97% -$64.1K ﹤0.01% 6031
2023
Q2
$24.7K Sell
75,907
-70,826
-48% -$25.4K ﹤0.01% 5676
2023
Q1
$63.1K Buy
146,733
+88,629
+153% +$46.7K ﹤0.01% 5047
2022
Q4
$30.8K Sell
58,104
-30,714
-35% -$19.5K ﹤0.01% 5081
2022
Q3
$64K Buy
88,818
+212
+0.2% +$241 ﹤0.01% 4833
2022
Q2
$101K Buy
88,606
+29,172
+49% +$37.1K ﹤0.01% 4636
2022
Q1
$123K Buy
59,434
+23,936
+67% +$56.9K ﹤0.01% 5221
2021
Q4
$102K Sell
35,498
-336
-0.9% -$1.24K ﹤0.01% 5625
2021
Q3
$151K Buy
35,834
+506
+1% +$2.26K ﹤0.01% 5212
2021
Q2
$186K Buy
35,328
+6,400
+22% +$30.8K ﹤0.01% 5063
2021
Q1
$134K Buy
28,928
+26,458
+1,071% +$120K ﹤0.01% 5346
2020
Q4
$8K Buy
2,470
+831
+51% +$3.15K ﹤0.01% 6078
2020
Q3
$5K Sell
1,639
-2,792
-63% -$10.3K ﹤0.01% 6027
2020
Q2
$15K Sell
4,431
-17,893
-80% -$84.6K ﹤0.01% 5769
2020
Q1
$86K Sell
22,324
-2,051
-8% -$9.53K ﹤0.01% 5140
2019
Q4
$147K Buy
24,375
+8,058
+49% +$55.1K ﹤0.01% 5128
2019
Q3
$123K Buy
16,317
+12,112
+288% +$137K ﹤0.01% 5229
2019
Q2
$57K Buy
4,205
+2,204
+110% +$25.4K ﹤0.01% 5508
2019
Q1
$10K Sell
2,001
-838
-30% -$4.08K ﹤0.01% 5645
2018
Q4
$8K Sell
2,839
-5,467
-66% -$29.9K ﹤0.01% 5997
2018
Q3
$68K Sell
8,306
-49,515
-86% -$380K ﹤0.01% 5499
2018
Q2
$563K Buy
57,821
+16,407
+40% +$168K ﹤0.01% 4359
2018
Q1
$360K Buy
41,414
+6,782
+20% +$73.1K ﹤0.01% 4627
2017
Q4
$434K Buy
34,632
+553
+2% +$6.34K ﹤0.01% 4498
2017
Q3
$285K Buy
34,079
+33,196
+3,759% +$351K ﹤0.01% 4711
2017
Q2
$15K Buy
883
+200
+29% +$3.98K ﹤0.01% 5690
2017
Q1
$14K Sell
683
-204
-23% -$4.05K ﹤0.01% 5793
2016
Q4
$14K Buy
887
+387
+77% +$5.21K ﹤0.01% 5717
2016
Q3
$7K Buy
500
+400
+400% +$3.8K ﹤0.01% 5845
2016
Q2
$1K Sell
100
-254
-72% -$2.13K ﹤0.01% 6038
2016
Q1
$3K Buy
354
+247
+231% +$1.99K ﹤0.01% 5979
2015
Q4
$1K Sell
107
-7
-6% -$93 ﹤0.01% 6127
2015
Q3
$1K Buy
+114
New +$2.8K ﹤0.01% 6094